Lilly Licenses InnoCare Discovery Programs

Company InnoCare Pharma / Eli Lilly Event Type Research Collaboration and License Agreement Modality Undisclosed Asset Discovery Programs Against Up to Five Targets Target Undisclosed (Up to Five Targets) Disease Area Undisclosed (Oncology / Autoimmune Platform) Summary InnoCare Pharma entered a research collaboration and license…